পদ্ধতির তুলনা করুন

	হাইপারথাইরয়েডিজম উপসর্গ তালিকা	TED-QoL / GO-QoL: থাইরয়েড আই ডিজিজ কোয়ালিটি অফ লাইফ প্রশ্নাবলী
ক্ষেত্র	অন্তঃক্ষরা বিজ্ঞান	অন্তঃক্ষরা বিজ্ঞান
পরিবার	Process / pipeline	Process / pipeline
উদ্ভবের বছর	1997	2001
প্রবর্তক	Multiple authors; consensus from Endocrine Society	Caroline Terwee, Markus Gerding, Frank Dekker
ধরন	Patient self-report symptom checklist	Patient self-report questionnaire
মৌলিক উৎস	Engel, G. L., Dayan, A. D., Thorn, G. W., et al. (1997). Hyperthyroidism: A multisystem disease with diverse manifestations. Adv Intern Med, 42, 55-91.	Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779.
অপর নাম	HSC, Hyperthyroid Symptom Inventory	GO-QoL, Graves Ophthalmopathy Quality of Life
সম্পর্কিত	3	3
সারসংক্ষেপ	The Hyperthyroidism Symptom Checklist is a structured assessment tool for quantifying the symptom burden of Graves' disease and other thyrotoxicosis conditions. It captures the multisystem manifestations of excess thyroid hormone: cardiovascular (palpitations, tachycardia, arrhythmia), neuropsychiatric (anxiety, tremor, insomnia), metabolic (heat intolerance, weight loss, appetite), and eye-specific symptoms (in Graves' ophthalmopathy). Used in endocrinology practice and clinical trials to monitor disease activity and treatment response.	The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment.